Reduced Thiamine Availability and Hyperglycemia Impair Thiamine Transport in Renal Glomerular Cells through Modulation of Thiamine Transporter 2
暂无分享,去创建一个
M. Porta | G. Gruden | F. Barutta | M. Trento | Linda Bellucci | E. Beltramo | A. Mazzeo
[1] M. Porta,et al. Thiamine transporter 2 is involved in high glucose-induced damage and altered thiamine availability in cell models of diabetic retinopathy , 2019, Diabetes & vascular disease research.
[2] K. Kankova,et al. Transketolase Activity but not Thiamine Membrane Transport Change in Response to Hyperglycaemia and Kidney Dysfunction. , 2017, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[3] A. Paterson,et al. Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes , 2015, Diabetes.
[4] Katarína Kuricová,et al. Evidence for altered thiamine metabolism in diabetes: Is there a potential to oppose gluco- and lipotoxicity by rational supplementation? , 2014, World journal of diabetes.
[5] Garry K. Brown. Defects of thiamine transport and metabolism , 2014, Journal of Inherited Metabolic Disease.
[6] H. Said,et al. Adaptive regulation of human intestinal thiamine uptake by extracellular substrate level: a role for THTR-2 transcriptional regulation. , 2013, American journal of physiology. Gastrointestinal and liver physiology.
[7] Paul J Thornalley,et al. Glucose-Induced Down Regulation of Thiamine Transporters in the Kidney Proximal Tubular Epithelium Produces Thiamine Insufficiency in Diabetes , 2012, PloS one.
[8] H. Moradi,et al. Effect of chronic kidney disease on the expression of thiamin and folic acid transporters. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] Hitoshi Suzuki,et al. Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy. , 2009, The New England journal of medicine.
[10] Elena Berrone,et al. Different apoptotic responses of human and bovine pericytes to fluctuating glucose levels and protective role of thiamine , 2009, Diabetes/metabolism research and reviews.
[11] M. Porta,et al. Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications , 2008, Acta Diabetologica.
[12] R. Babaei-Jadidi,et al. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease , 2007, Diabetologia.
[13] N. Vaziri,et al. Vitamin B1 (thiamine) uptake by human retinal pigment epithelial (ARPE‐19) cells: mechanism and regulation , 2007, The Journal of physiology.
[14] Elena Berrone,et al. Regulation of Intracellular Glucose and Polyol Pathway by Thiamine and Benfotiamine in Vascular Cells Cultured in High Glucose* , 2006, Journal of Biological Chemistry.
[15] C. Ricketts,et al. Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families. , 2006, Acta paediatrica.
[16] H. Said,et al. Characterization of the 5'-regulatory region of the human thiamin transporter SLC19A3: in vitro and in vivo studies. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[17] Antonio Ceriello,et al. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. , 2003, Diabetes.
[18] H. Said,et al. In vitro and in vivo characterization of the minimal promoter region of the human thiamin transporter SLC19A2. , 2003, American journal of physiology. Cell physiology.
[19] R. Babaei-Jadidi,et al. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. , 2003, Diabetes.
[20] Xin Lu,et al. Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis. , 2003, Molecular cancer research : MCR.
[21] H. Hammes,et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy , 2003, Nature Medicine.
[22] M. O'hare,et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. , 2002, Journal of the American Society of Nephrology : JASN.
[23] A. Albert,et al. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. , 2001, Diabetes care.
[24] E. Neufeld,et al. Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport. , 2001, Blood cells, molecules & diseases.
[25] B. Wlodarczyk,et al. Identification and characterization of the human and mouse SLC19A3 gene: a novel member of the reduced folate family of micronutrient transporter genes. , 2000, Molecular genetics and metabolism.
[26] G. Rindi,et al. Thiamine Intestinal Transport and Related Issues: Recent Aspects , 2000 .
[27] G. Rindi,et al. Transport of thiamin in rat renal brush border membrane vesicles. , 2000, Kidney international.
[28] G. Camussi,et al. HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. , 1998, The Journal of clinical investigation.
[29] G. Gascon,et al. Biotin-responsive basal ganglia disease: a novel entity. , 1998, Brain : a journal of neurology.
[30] M. Porta,et al. Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions , 1996, Diabetologia.
[31] The Absence of a Glycemic Threshold for the Development of Long-Term Complications: The Perspective of the Diabetes Control and Complications Trial , 1996, Diabetes.
[32] J. E. Buttery,et al. A Stable Reagent Mixture for the Whole Blood Transketolase Assay , 1996, Annals of clinical biochemistry.
[33] The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. , 1996, Diabetes.